| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.33e-07 | 27 | 102 | 5 | GO:0004683 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 3.38e-07 | 363 | 102 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 4.45e-07 | 446 | 102 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CAMK1D PAK5 MAP3K20 DGKA RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 PI4KB STK33 DGKK MAP3K11 MAPK6 EIF2AK2 PRKX | 5.95e-07 | 709 | 102 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | CAMK1D PAK5 MAP3K20 DGKA RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 PI4KB STK33 DGKK MAP3K11 MAPK6 EIF2AK2 PRKX | 1.58e-06 | 764 | 102 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CAMK1D PAK5 MAP3K20 DGKA RIOK3 CAMK1G MAPKAPK5 MYLK2 POLR3F PHKG1 PI4KB STK33 DGKK MAP3K11 MAPK6 EIF2AK2 PRKX | 5.08e-06 | 938 | 102 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 1.15e-05 | 600 | 102 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.51e-05 | 10 | 102 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | CTP binding | 2.58e-05 | 2 | 102 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 7.73e-05 | 3 | 102 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | UTP binding | 1.54e-04 | 4 | 102 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 2.13e-04 | 23 | 102 | 3 | GO:0010314 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 2.56e-04 | 5 | 102 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 2.56e-04 | 5 | 102 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 3.82e-04 | 6 | 102 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 5.34e-04 | 7 | 102 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | TPR domain binding | 7.09e-04 | 8 | 102 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 7.09e-04 | 8 | 102 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 8.17e-04 | 36 | 102 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 9.09e-04 | 9 | 102 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 1.03e-03 | 39 | 102 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.11e-03 | 40 | 102 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.17e-03 | 230 | 102 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.20e-03 | 41 | 102 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | kinase binding | BLNK GRIA1 GRIN2A MAPKAPK5 EIF4ENIF1 FAM83F MAP3K11 MAPK6 CDH5 ATP2B4 MOB4 HSP90AA1 HSP90AB1 | 1.30e-03 | 969 | 102 | 13 | GO:0019900 |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.32e-03 | 93 | 102 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.38e-03 | 11 | 102 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 1.38e-03 | 11 | 102 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.65e-03 | 12 | 102 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 1.89e-03 | 48 | 102 | 3 | GO:0032266 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.34e-03 | 17 | 102 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.57e-03 | 599 | 102 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 3.99e-03 | 126 | 102 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 4.62e-03 | 20 | 102 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 4.62e-03 | 20 | 102 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | protein kinase binding | BLNK GRIA1 GRIN2A MAPKAPK5 FAM83F MAP3K11 MAPK6 CDH5 ATP2B4 HSP90AA1 HSP90AB1 | 4.98e-03 | 873 | 102 | 11 | GO:0019901 |
| Domain | Ser/Thr_kinase_AS | CAMK1D PAK5 MAP3K20 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 6.35e-07 | 357 | 103 | 12 | IPR008271 |
| Domain | S_TKc | CAMK1D PAK5 MAP3K20 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 6.74e-07 | 359 | 103 | 12 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CAMK1D PAK5 MAP3K20 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 7.36e-07 | 362 | 103 | 12 | PS00108 |
| Domain | Kinase-like_dom | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 PI4KB STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 1.63e-06 | 542 | 103 | 14 | IPR011009 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.20e-06 | 69 | 103 | 6 | IPR020636 | |
| Domain | Prot_kinase_dom | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 2.90e-06 | 489 | 103 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CAMK1D PAK5 MAP3K20 RIOK3 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 3.17e-06 | 493 | 103 | 13 | PS50011 |
| Domain | Pkinase | CAMK1D PAK5 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 8.20e-06 | 381 | 103 | 11 | PF00069 |
| Domain | PROTEIN_KINASE_ATP | CAMK1D PAK5 MAP3K20 CAMK1G MAPKAPK5 MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 8.50e-06 | 459 | 103 | 12 | PS00107 |
| Domain | Protein_kinase_ATP_BS | CAMK1D PAK5 CAMK1G MYLK2 PHKG1 STK33 MAP3K11 MAPK6 EIF2AK2 PRKX | 4.64e-05 | 379 | 103 | 10 | IPR017441 |
| Domain | DBINO | 9.00e-05 | 3 | 103 | 2 | PF13892 | |
| Domain | DBINO | 9.00e-05 | 3 | 103 | 2 | IPR020838 | |
| Domain | Heat_shock_protein_90_CS | 9.00e-05 | 3 | 103 | 2 | IPR019805 | |
| Domain | Tscrpt_reg_Myc_N | 1.79e-04 | 4 | 103 | 2 | IPR012682 | |
| Domain | Tscrpt_reg_Myc | 1.79e-04 | 4 | 103 | 2 | IPR002418 | |
| Domain | Hsp90_fam | 1.79e-04 | 4 | 103 | 2 | IPR001404 | |
| Domain | Hsp90_N | 1.79e-04 | 4 | 103 | 2 | IPR020575 | |
| Domain | Myc_N | 1.79e-04 | 4 | 103 | 2 | PF01056 | |
| Domain | HSP90 | 1.79e-04 | 4 | 103 | 2 | PF00183 | |
| Domain | HSP90 | 1.79e-04 | 4 | 103 | 2 | PS00298 | |
| Domain | FN3 | 8.24e-04 | 199 | 103 | 6 | PS50853 | |
| Domain | FN3_dom | 1.06e-03 | 209 | 103 | 6 | IPR003961 | |
| Domain | DAGK_acc | 1.32e-03 | 10 | 103 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.32e-03 | 10 | 103 | 2 | IPR000756 | |
| Domain | DAGKa | 1.32e-03 | 10 | 103 | 2 | SM00045 | |
| Domain | PH | 1.69e-03 | 229 | 103 | 6 | PF00169 | |
| Domain | fn3 | 2.04e-03 | 162 | 103 | 5 | PF00041 | |
| Domain | DAGKc | 2.62e-03 | 14 | 103 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 3.02e-03 | 15 | 103 | 2 | IPR001206 | |
| Domain | DAGK_cat | 3.02e-03 | 15 | 103 | 2 | PF00781 | |
| Domain | DAGK | 3.02e-03 | 15 | 103 | 2 | PS50146 | |
| Domain | FN3 | 3.62e-03 | 185 | 103 | 5 | SM00060 | |
| Domain | Gal_mutarotase_SF_dom | 3.88e-03 | 17 | 103 | 2 | IPR011013 | |
| Domain | NAD/diacylglycerol_kinase | 3.88e-03 | 17 | 103 | 2 | IPR016064 | |
| Domain | Iontro_rcpt | 4.35e-03 | 18 | 103 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 4.35e-03 | 18 | 103 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 4.35e-03 | 18 | 103 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 4.35e-03 | 18 | 103 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.35e-03 | 18 | 103 | 2 | SM00918 | |
| Domain | Lig_chan | 4.35e-03 | 18 | 103 | 2 | PF00060 | |
| Domain | PBPe | 4.35e-03 | 18 | 103 | 2 | SM00079 | |
| Domain | HATPase_c | 4.35e-03 | 18 | 103 | 2 | SM00387 | |
| Domain | PH | 4.42e-03 | 278 | 103 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.50e-03 | 279 | 103 | 6 | PS50003 | |
| Domain | PH_domain | 4.57e-03 | 280 | 103 | 6 | IPR001849 | |
| Domain | HATPase_c | 4.84e-03 | 19 | 103 | 2 | PF02518 | |
| Domain | DH_1 | 5.09e-03 | 63 | 103 | 3 | PS00741 | |
| Domain | ZF_DAG_PE_1 | 5.32e-03 | 64 | 103 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.32e-03 | 64 | 103 | 3 | PS50081 | |
| Domain | - | 5.36e-03 | 20 | 103 | 2 | 3.30.565.10 | |
| Domain | C1 | 5.55e-03 | 65 | 103 | 3 | SM00109 | |
| Domain | Ig-like_fold | MPL FNDC3B ADAMTSL3 PKHD1L1 PTGFRN PTPRM IGHG3 CNTN3 IGSF9 IL5RA | 5.59e-03 | 706 | 103 | 10 | IPR013783 |
| Domain | PE/DAG-bd | 5.80e-03 | 66 | 103 | 3 | IPR002219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 3.00e-06 | 19 | 77 | 4 | M47957 | |
| Pubmed | PACSIN1 PAK5 PLEKHA6 LCP2 MAPKAPK5 MAP3K11 PLEKHA5 AKAP13 MAPK6 MOB4 HSP90AA1 HSP90AB1 | 3.25e-08 | 486 | 106 | 12 | 20936779 | |
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 2.74e-07 | 5 | 106 | 3 | 17229826 | |
| Pubmed | Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling. | 2.74e-07 | 5 | 106 | 3 | 15001580 | |
| Pubmed | Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33. | 1.52e-06 | 8 | 106 | 3 | 22451720 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 16280321 | ||
| Pubmed | 8.35e-06 | 236 | 106 | 7 | 36339263 | ||
| Pubmed | Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. | 9.20e-06 | 2 | 106 | 2 | 15577943 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10376793 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 14694181 | ||
| Pubmed | Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. | 9.20e-06 | 2 | 106 | 2 | 33179566 | |
| Pubmed | Regulation of embryonic stem cell pluripotency by heat shock protein 90. | 9.20e-06 | 2 | 106 | 2 | 22696450 | |
| Pubmed | The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs. | 9.20e-06 | 2 | 106 | 2 | 3054516 | |
| Pubmed | Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. | 9.20e-06 | 2 | 106 | 2 | 18565157 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22895790 | ||
| Pubmed | Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. | 9.20e-06 | 2 | 106 | 2 | 22848402 | |
| Pubmed | Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. | 9.20e-06 | 2 | 106 | 2 | 19576239 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 9.20e-06 | 2 | 106 | 2 | 3458168 | |
| Pubmed | Mechanism of dimer formation of the 90-kDa heat-shock protein. | 9.20e-06 | 2 | 106 | 2 | 7588731 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2925609 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2469626 | ||
| Pubmed | Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. | 9.20e-06 | 2 | 106 | 2 | 2591742 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2827002 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33080545 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31885746 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37011862 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26651243 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36270993 | ||
| Pubmed | Hsp90 regulation of fibroblast activation in pulmonary fibrosis. | 9.20e-06 | 2 | 106 | 2 | 28239659 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 39232006 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37028636 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37406487 | ||
| Pubmed | Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. | 9.20e-06 | 2 | 106 | 2 | 22194440 | |
| Pubmed | Circadian expression of 86- and 84-kDa heat shock proteins in the mouse suprachiasmatic nucleus. | 9.20e-06 | 2 | 106 | 2 | 18480550 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22841823 | ||
| Pubmed | Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. | 9.20e-06 | 2 | 106 | 2 | 18347946 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19047110 | ||
| Pubmed | Conserved conformational changes in the ATPase cycle of human Hsp90. | 9.20e-06 | 2 | 106 | 2 | 18400751 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22019372 | ||
| Pubmed | The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. | 9.20e-06 | 2 | 106 | 2 | 15723073 | |
| Pubmed | Two dimensional Blue Native-/SDS-PAGE analysis of SLP family adaptor protein complexes. | 9.20e-06 | 2 | 106 | 2 | 16356554 | |
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 9.20e-06 | 2 | 106 | 2 | 12136260 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 1.50e-05 | 16 | 106 | 3 | 16269234 | |
| Pubmed | 2.09e-05 | 272 | 106 | 7 | 31010829 | ||
| Pubmed | 2.17e-05 | 18 | 106 | 3 | 12588844 | ||
| Pubmed | ATXN2L SMARCA5 MAP3K20 PLEKHA6 ZC3H4 MAP3K11 PLEKHA5 AKAP13 HSP90AB1 | 2.45e-05 | 503 | 106 | 9 | 16964243 | |
| Pubmed | The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. | 2.76e-05 | 3 | 106 | 2 | 11447118 | |
| Pubmed | A pilot proteomic study with a prospective cohort suspected to develop preeclampsia. | 2.76e-05 | 3 | 106 | 2 | 32472113 | |
| Pubmed | Molecular recognition via coupled folding and binding in a TPR domain. | 2.76e-05 | 3 | 106 | 2 | 15713458 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2492519 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 1406681 | ||
| Pubmed | Identification of neuronal substrates implicates Pak5 in synaptic vesicle trafficking. | 2.76e-05 | 3 | 106 | 2 | 22371566 | |
| Pubmed | Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. | 2.76e-05 | 3 | 106 | 2 | 15642353 | |
| Pubmed | Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. | 2.76e-05 | 3 | 106 | 2 | 20226818 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34613798 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10995457 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20937816 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18550790 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29754475 | ||
| Pubmed | N-terminal domain of human Hsp90 triggers binding to the cochaperone p23. | 2.76e-05 | 3 | 106 | 2 | 21183720 | |
| Pubmed | Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis. | 2.76e-05 | 3 | 106 | 2 | 29386344 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22843495 | ||
| Pubmed | HSP90 affects the stability of BMAL1 and circadian gene expression. | 2.76e-05 | 3 | 106 | 2 | 24682203 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33355366 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19158073 | ||
| Pubmed | Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. | 2.76e-05 | 3 | 106 | 2 | 22849407 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16973613 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 15146192 | ||
| Pubmed | Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. | 2.76e-05 | 3 | 106 | 2 | 16531226 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33145341 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19996089 | ||
| Pubmed | HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. | 2.76e-05 | 3 | 106 | 2 | 29768689 | |
| Pubmed | Hsp90 activity is necessary to acquire a proper neuronal polarization. | 2.76e-05 | 3 | 106 | 2 | 24286867 | |
| Pubmed | Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures. | 2.76e-05 | 3 | 106 | 2 | 15358771 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24511009 | ||
| Pubmed | Chaperone ligand-discrimination by the TPR-domain protein Tah1. | 2.76e-05 | 3 | 106 | 2 | 18412542 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16698020 | ||
| Pubmed | HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. | 2.76e-05 | 3 | 106 | 2 | 18195352 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17681949 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18720373 | ||
| Pubmed | 3.52e-05 | 21 | 106 | 3 | 23428871 | ||
| Pubmed | SART3 FNDC3B MAN2A1 GEMIN2 KDM5A MAP3K20 INO80 OLA1 WRAP53 MYLK2 EIF4ENIF1 ANAPC1 PWP2 ANKRD11 EIF2AK2 | 4.91e-05 | 1497 | 106 | 15 | 31527615 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 35043518 | ||
| Pubmed | Functional requirement of p23 and Hsp90 in telomerase complexes. | 5.50e-05 | 4 | 106 | 2 | 10197982 | |
| Pubmed | The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. | 5.50e-05 | 4 | 106 | 2 | 19234166 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 11487585 | ||
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 5.50e-05 | 4 | 106 | 2 | 1740332 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 7479755 | ||
| Pubmed | The E3 ligase CHIP mediates ubiquitination and degradation of mixed-lineage kinase 3. | 5.50e-05 | 4 | 106 | 2 | 24912674 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 16394098 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 34174923 | ||
| Pubmed | HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients. | 5.50e-05 | 4 | 106 | 2 | 28636940 | |
| Pubmed | Cloning and characterization of a family of proteins associated with Mpl. | 5.50e-05 | 4 | 106 | 2 | 11784712 | |
| Pubmed | Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. | 5.50e-05 | 4 | 106 | 2 | 15782121 | |
| Pubmed | Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation. | 5.50e-05 | 4 | 106 | 2 | 17178836 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 27418101 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 12482853 | ||
| Pubmed | Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. | 5.50e-05 | 4 | 106 | 2 | 12117999 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 22367781 | ||
| Pubmed | Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3. | 5.50e-05 | 4 | 106 | 2 | 12559950 | |
| Pubmed | Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis. | 5.50e-05 | 4 | 106 | 2 | 28143869 | |
| Interaction | UNC45B interactions | 4.56e-06 | 22 | 104 | 4 | int:UNC45B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 6.54e-05 | 294 | 106 | 6 | chr1p34 | |
| GeneFamily | Heat shock 90kDa proteins | 1.34e-04 | 5 | 67 | 2 | 586 | |
| GeneFamily | Fibronectin type III domain containing | 3.16e-04 | 160 | 67 | 5 | 555 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 5.97e-04 | 10 | 67 | 2 | 1178 | |
| GeneFamily | Immunoglobulin like domain containing | 7.44e-04 | 193 | 67 | 5 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.88e-03 | 66 | 67 | 3 | 722 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.00e-03 | 161 | 67 | 4 | 593 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.25e-03 | 23 | 67 | 2 | 662 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.54e-03 | 24 | 67 | 2 | 654 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-07 | 157 | 106 | 7 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.19e-07 | 200 | 106 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 3.32e-06 | 170 | 106 | 6 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.47e-06 | 179 | 106 | 6 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 179 | 106 | 6 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 181 | 106 | 6 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.24e-06 | 184 | 106 | 6 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.41e-06 | 185 | 106 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-06 | 187 | 106 | 6 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.89e-06 | 193 | 106 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 7.09e-06 | 194 | 106 | 6 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 7.09e-06 | 194 | 106 | 6 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-06 | 194 | 106 | 6 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-06 | 196 | 106 | 6 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 196 | 106 | 6 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 198 | 106 | 6 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 198 | 106 | 6 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.20e-06 | 199 | 106 | 6 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells|Control_saline / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | a4d6525e70de39802ff9fdef0d877c4463a6200d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 8.44e-06 | 200 | 106 | 6 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.88e-05 | 149 | 106 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.88e-05 | 149 | 106 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-05 | 155 | 106 | 5 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 162 | 106 | 5 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 162 | 106 | 5 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 162 | 106 | 5 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 162 | 106 | 5 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 162 | 106 | 5 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 167 | 106 | 5 | 691f3589de0f8c13f9137812cfa9040c07d237b4 | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 5.41e-05 | 170 | 106 | 5 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 171 | 106 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 171 | 106 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.04e-05 | 174 | 106 | 5 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 178 | 106 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 179 | 106 | 5 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.90e-05 | 179 | 106 | 5 | dc0b806904ef4c2f74f34ade2b1c0d6893f3b2ec | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 180 | 106 | 5 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 180 | 106 | 5 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 181 | 106 | 5 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.66e-05 | 183 | 106 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 184 | 106 | 5 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 185 | 106 | 5 | 0fa7970709dc957dea95fabbd83263a0335babd5 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 185 | 106 | 5 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | metastatic_Brain-B_lymphocytes|metastatic_Brain / Location, Cell class and cell subclass | 8.06e-05 | 185 | 106 | 5 | 153b82dc5ace03f84dc82d724d56bdc93aa020df | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 186 | 106 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-05 | 186 | 106 | 5 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 188 | 106 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.87e-05 | 98 | 106 | 4 | 7a62a77ca83153dacff4d02d6e32104227d0980d | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.87e-05 | 98 | 106 | 4 | 26250ea4171a0557a67505839cf79d3fe4d9d41a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.87e-05 | 98 | 106 | 4 | 42875d16ae9fcbaf988cd71be82568f2f862f2dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.92e-05 | 189 | 106 | 5 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-05 | 190 | 106 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.37e-05 | 191 | 106 | 5 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.37e-05 | 191 | 106 | 5 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 192 | 106 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-05 | 193 | 106 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-05 | 193 | 106 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 193 | 106 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 194 | 106 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 194 | 106 | 5 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 195 | 106 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-04 | 195 | 106 | 5 | fb3d6a3b10aedc7fdd9789b2c47b4e80fa8e411f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 196 | 106 | 5 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.06e-04 | 196 | 106 | 5 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-04 | 197 | 106 | 5 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-04 | 197 | 106 | 5 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-04 | 197 | 106 | 5 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.08e-04 | 197 | 106 | 5 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 1.08e-04 | 197 | 106 | 5 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.11e-04 | 198 | 106 | 5 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 106 | 5 | f197ab861767ee06aa47b86c537fb3d8c2b2bc3e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 58b25dc2d29e98354bfc8e8e161796c237c3dc23 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.16e-04 | 200 | 106 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-04 | 115 | 106 | 4 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 128 | 106 | 4 | a190aa5a6db9c4120f4667af40ac3da2f267d4da | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.21e-04 | 137 | 106 | 4 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-04 | 139 | 106 | 4 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 139 | 106 | 4 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 139 | 106 | 4 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-04 | 142 | 106 | 4 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| Drug | neotrehalose | MPL PACSIN1 SI GRIN2A CNTN3 EIF2AK2 HSP90AA1 HSP90AA2P HSP90AB1 | 6.66e-07 | 214 | 105 | 9 | CID000001143 |
| Drug | NSC330499 | 3.29e-06 | 7 | 105 | 3 | CID000433447 | |
| Drug | phenyldichloroarsine | 5.25e-06 | 8 | 105 | 3 | CID000012762 | |
| Drug | benzoquinone | PACSIN1 SI GRIN2A EIF2AK2 ATP2B4 HSP90AA1 HSP90AA2P HSP90AB1 | 5.74e-06 | 209 | 105 | 8 | CID000004650 |
| Drug | 5,8-quinolinedione | 7.85e-06 | 9 | 105 | 3 | CID000388306 | |
| Drug | Pu-3 | 1.53e-05 | 11 | 105 | 3 | CID000448965 | |
| Drug | kainite | 2.00e-05 | 35 | 105 | 4 | CID000164810 | |
| Drug | 3-amino-5-chlorobenzoic acid | 2.11e-05 | 2 | 105 | 2 | CID010986726 | |
| Drug | monocillin III | 2.11e-05 | 2 | 105 | 2 | CID006478910 | |
| Drug | pochonin A | 2.11e-05 | 2 | 105 | 2 | CID006478909 | |
| Drug | PU-H71 | 2.11e-05 | 2 | 105 | 2 | CID009549213 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 2.11e-05 | 2 | 105 | 2 | DB02754 | |
| Drug | 1uyc | 2.11e-05 | 2 | 105 | 2 | CID000448969 | |
| Drug | PU-9 | 2.11e-05 | 2 | 105 | 2 | CID000448971 | |
| Drug | P u 0 | 2.11e-05 | 2 | 105 | 2 | CID000448974 | |
| Drug | 2qf6 | 2.11e-05 | 2 | 105 | 2 | CID013373715 | |
| Drug | Geldanamycin | 2.11e-05 | 2 | 105 | 2 | DB02424 | |
| Drug | CHEBI:42139 | 2.11e-05 | 2 | 105 | 2 | CID011562562 | |
| Drug | 2qfo | 2.11e-05 | 2 | 105 | 2 | CID000600769 | |
| Drug | 3eko | 2.11e-05 | 2 | 105 | 2 | CID011160307 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 2.11e-05 | 2 | 105 | 2 | DB07877 | |
| Drug | 1uyi | 2.11e-05 | 2 | 105 | 2 | CID005289232 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 2.11e-05 | 2 | 105 | 2 | DB07594 | |
| Drug | NSC683666 | 2.11e-05 | 2 | 105 | 2 | CID005469153 | |
| Drug | H 64 | 2.11e-05 | 2 | 105 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 2.11e-05 | 2 | 105 | 2 | CID015942101 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 3.19e-05 | 193 | 105 | 7 | 3412_DN | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 3508_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A | 3.52e-05 | 196 | 105 | 7 | 1586_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 3.75e-05 | 198 | 105 | 7 | 1588_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 4.00e-05 | 200 | 105 | 7 | 5996_DN | |
| Drug | AC1L9PMA | 4.17e-05 | 15 | 105 | 3 | CID000451405 | |
| Drug | pochonin D | 6.30e-05 | 3 | 105 | 2 | CID006478913 | |
| Drug | azaquinone | 6.30e-05 | 3 | 105 | 2 | CID000099132 | |
| Drug | d 1 v | 6.30e-05 | 3 | 105 | 2 | CID000683940 | |
| Drug | AC1MD0RC | 6.30e-05 | 3 | 105 | 2 | CID002829073 | |
| Drug | HM-9 | 6.30e-05 | 3 | 105 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 6.30e-05 | 3 | 105 | 2 | CID000133564 | |
| Drug | gamma-Glutamylglutamate | 1.03e-04 | 20 | 105 | 3 | CID000092865 | |
| Drug | dimethyl pimelimidate | 1.03e-04 | 20 | 105 | 3 | CID000065403 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 1.26e-04 | 4 | 105 | 2 | ctd:C576667 | |
| Drug | uranyl chloride | 1.26e-04 | 4 | 105 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 1.26e-04 | 4 | 105 | 2 | CID000069988 | |
| Drug | Poly C | 1.26e-04 | 4 | 105 | 2 | ctd:D011066 | |
| Drug | 11p110 | 1.26e-04 | 4 | 105 | 2 | CID002382787 | |
| Drug | tamoxifen aziridine | 1.38e-04 | 22 | 105 | 3 | CID003033894 | |
| Drug | CCT018159 | 1.38e-04 | 22 | 105 | 3 | CID005327091 | |
| Drug | Ra X Peptide | 1.50e-04 | 58 | 105 | 4 | CID006444175 | |
| Drug | S2A | 1.58e-04 | 23 | 105 | 3 | CID016058643 | |
| Drug | oleth-3-phosphate | 1.71e-04 | 60 | 105 | 4 | CID000021452 | |
| Drug | fenthion | 1.80e-04 | 24 | 105 | 3 | CID000003346 | |
| Drug | HF-2035 | 2.04e-04 | 25 | 105 | 3 | CID006439511 | |
| Drug | 1uyd | 2.09e-04 | 5 | 105 | 2 | CID000448970 | |
| Drug | HCV-796 | 2.09e-04 | 5 | 105 | 2 | CID011561383 | |
| Drug | chaetochromin | 2.09e-04 | 5 | 105 | 2 | CID000053277 | |
| Drug | 1,1-diphenyl-2-propyn-1-ol | 2.09e-04 | 5 | 105 | 2 | CID000092976 | |
| Drug | 1uy7 | 2.09e-04 | 5 | 105 | 2 | CID005289227 | |
| Drug | Org 31806 | 2.09e-04 | 5 | 105 | 2 | CID000164147 | |
| Drug | CRT0044876 | 2.09e-04 | 5 | 105 | 2 | CID000081409 | |
| Drug | CTK8G2960 | 2.26e-04 | 186 | 105 | 6 | CID005361912 | |
| Disease | blood copper measurement | 2.85e-05 | 50 | 103 | 4 | EFO_0007578 | |
| Disease | Morphine Abuse | 2.51e-04 | 7 | 103 | 2 | C0600272 | |
| Disease | Morphine Dependence | 2.51e-04 | 7 | 103 | 2 | C0026552 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 4.30e-04 | 42 | 103 | 3 | DOID:612 (is_implicated_in) | |
| Disease | carbohydrate measurement | 5.62e-04 | 46 | 103 | 3 | EFO_0004998 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 6.50e-04 | 11 | 103 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | cesarean section, intelligence | 7.78e-04 | 12 | 103 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | idiopathic pulmonary fibrosis | 1.05e-03 | 57 | 103 | 3 | EFO_0000768 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.40e-03 | 16 | 103 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | grip strength measurement | 1.45e-03 | 350 | 103 | 6 | EFO_0006941 | |
| Disease | sexual dimorphism measurement | ATXN2L FNDC3B CACNA2D2 PACSIN1 RIOK3 GRIN2A ADAMTSL3 ZC3H4 SF3A3 ANKRD11 MAP3K11 | 1.68e-03 | 1106 | 103 | 11 | EFO_0021796 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.77e-03 | 364 | 103 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:4928 (is_marker_for) | |
| Disease | corneal hysteresis | 2.20e-03 | 20 | 103 | 2 | EFO_0010066 | |
| Disease | Huntington's disease (is_implicated_in) | 2.91e-03 | 23 | 103 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | frailty measurement | 2.91e-03 | 23 | 103 | 2 | EFO_0009885 | |
| Disease | Periodontal Pocket | 3.44e-03 | 25 | 103 | 2 | EFO_1001393 | |
| Disease | Ataxia | 3.44e-03 | 25 | 103 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWALFPPSDDYDDTD | 416 | Q9H313 | |
| NPFGEDDDDFETNWC | 296 | Q8N1M1 | |
| VGTEESDFEGWAFPF | 56 | Q9NXW9 | |
| ASPDEVDDTYLQEFW | 426 | Q8N7J2 | |
| DEGYWDSTTPGPEED | 521 | Q8N7J2 | |
| EYGWSSSEFESYEEQ | 271 | O15013 | |
| YDPEDTWQDEEYFGS | 91 | P55345 | |
| DFKGEDSWDSPVTDY | 851 | Q6UB99 | |
| EDWTENPEPFNASFY | 776 | Q9NY47 | |
| APSRGEDDGESFYTW | 221 | Q86YB8 | |
| EENAGEPDSWSSLSY | 221 | Q12802 | |
| SDSDVDYDFLNDWGP | 751 | P33151 | |
| AYRDFDDTEPSWDNE | 641 | P23634 | |
| WEGGDSNSDDYDLES | 231 | Q8WWM7 | |
| DYGSPSQFWEQELES | 166 | A6NI79 | |
| EEPDSAAKSGEAWYE | 191 | Q9UF12 | |
| AFDDDSTSWAYQEGI | 251 | Q52LD8 | |
| EYFFTAGPDEVRAWT | 306 | Q9NTK5 | |
| TAADTVIFYDSDWNP | 1186 | Q9ULG1 | |
| ARPSETGSDDDWEYL | 696 | Q9H1A4 | |
| CEPQWFYEETESSDD | 36 | Q96K31 | |
| AYSESEWGPSLDDYD | 251 | Q9P286 | |
| FWGSNTATTEYEAPA | 946 | Q5KSL6 | |
| DDEQYAWESSAGGSF | 151 | P08238 | |
| GSFEFPEEEWSQISE | 261 | Q8IW41 | |
| GFDITYESNEWDTEP | 151 | Q16706 | |
| EYLSNWFGERDFTPE | 196 | O14893 | |
| WDEQGAHPSEDNDFY | 256 | Q8N386 | |
| STYDRDNDGWLTSDP | 406 | P02675 | |
| EDPAFDTNYSTEPCW | 411 | Q16659 | |
| SGNWYFDEETFEAVS | 496 | Q9H1R3 | |
| EIDYDGSGSVSQAEW | 166 | P23743 | |
| DTLDNGDYGEPDYDW | 141 | Q8NC54 | |
| PDYDWTTGPRDDDES | 151 | Q8NC54 | |
| QYDADAEETGLDGSW | 1171 | Q5T7B8 | |
| GEDFYRSTTPSEDIW | 16 | P12525 | |
| DDEDSYPQGGWDTVF | 21 | Q8TDT2 | |
| SGEDFAEWCEFTPYE | 506 | Q68DD2 | |
| EVPQESWDEGYSTLS | 826 | Q3BBV0 | |
| IPSKYDWSGAEESDD | 1591 | P29375 | |
| QPVFSGEDYDQWAVD | 1201 | P78509 | |
| YEFESPFWDDISESA | 236 | Q96NX5 | |
| APEETTDSFWEVGNY | 11 | Q9BY11 | |
| DRGQPYATEWSDDES | 351 | Q9BY11 | |
| YATEWSDDESGNPFG | 356 | Q9BY11 | |
| AYWAQAEDTAAPAEE | 266 | Q8NA61 | |
| TWLVGTDAPEDTQYF | 156 | Q01344 | |
| DYASESPADEEEQWS | 51 | Q8WV28 | |
| EEQWSDDFDSDYENP | 61 | Q8WV28 | |
| CWDGFDYDPETSDDS | 326 | P19525 | |
| YDWSEPFSPGEDEFK | 466 | Q86TI2 | |
| LTWEAVPGSEFSYAE | 381 | Q9Y6R7 | |
| GWESPDSSGADISEY | 786 | Q53EP0 | |
| PESWQQSCEGYEETD | 336 | Q9NX46 | |
| GGWETFLSYEDPDQD | 431 | Q9H9T3 | |
| VFADEDPATYVWDGN | 151 | Q92839 | |
| LPSFEIGAWTEDDVY | 331 | Q9NYL2 | |
| AEISEEPAEWSSNYF | 886 | P10911 | |
| GFYPSDIAVEWESSG | 301 | P01860 | |
| DDEQYAWESSAGGSF | 156 | P07900 | |
| SPYEWHSEEFEEGRD | 561 | P42261 | |
| DEQSDWFYEKESGGA | 281 | Q9NW75 | |
| EEPDSYTECTDGYEW | 31 | O95967 | |
| YTECTDGYEWDPDSQ | 36 | O95967 | |
| AESSPGEYEWEYDEE | 76 | Q15020 | |
| QPEYDSTDGEGDWSL | 211 | B1AKI9 | |
| AQFPSDEEYGFWSSD | 401 | O94829 | |
| AWIFNEYPSFVEEDS | 156 | Q9P232 | |
| DDEQYAWESSAGGSF | 156 | Q14568 | |
| WTALFDYEPSGQDEL | 46 | Q16584 | |
| GTNPEETAAEESWDY | 131 | P11049 | |
| KEEYESFFEGQSAPW | 901 | P28827 | |
| NYQFGSPEWDDYSDT | 246 | Q16816 | |
| SDYDGPSEQNFDWSF | 46 | Q9P2B2 | |
| SRDGDWPSSVEFYAS | 256 | Q96S99 | |
| WGNVPDANYTSDEEE | 431 | Q9BYT3 | |
| PAAEDEGDTAWNYSF | 136 | Q9BUR4 | |
| DFYNWPDESFDEMDS | 21 | Q9Y3A3 | |
| EVPQESWDEGYSTLS | 826 | Q5TAG4 | |
| GRGDNWYSEDEDTDT | 461 | Q9NVN3 | |
| WDQDPEQSTGNYSED | 41 | Q7Z5D8 | |
| VTGGAWYSDQDFESE | 161 | Q9H1D9 | |
| QGSLFWDDGESIDTY | 1721 | P14410 | |
| FSTVPNYDNDDEAWS | 446 | Q9UBF8 | |
| SGESLAYWPDRSDTE | 101 | Q8NEG4 | |
| AEYEFDSPYWDDISD | 236 | Q8IU85 | |
| NDSYTEEEPEWFSAG | 211 | Q9NRA8 | |
| ASPEKGAETWFDSYD | 216 | O75503 | |
| PYEDSDSSEDEVDWQ | 121 | O14730 | |
| EGFSYATEGESQEDW | 706 | Q8TBB6 | |
| YFFSAESPEEQEAWI | 136 | Q9Y2H5 | |
| GEDFYRSTAPSEDIW | 16 | P12524 | |
| FGPYDETTCIDWTDD | 141 | Q15269 | |
| SDETGWTTFFDYDSE | 1621 | Q9P273 | |
| GEYRDYSNDWSPSDT | 146 | Q9H9C1 | |
| EDYPGWSEDSFGARV | 3266 | Q86WI1 | |
| FWDEEEAAPSGTYQL | 51 | P40238 | |
| SVDENYEWDSEFPGD | 1081 | Q9P2J2 | |
| SNFETYPENDWDTAA | 331 | P51817 | |
| ENEEGDTGNWYSSDE | 796 | Q9UPT8 | |
| GSDTAVDAAFEPVYW | 56 | Q969W1 | |
| WDDETPGPSYSSSEQ | 416 | Q9NS56 | |
| GEEPWFSEEEFSNQS | 101 | Q9Y2H8 | |
| WQPDTEEEYEDSSGN | 471 | Q12874 | |
| GLSSTEDEGEDPWYQ | 21 | O15537 | |
| PDVFNSADDFDSWFD | 356 | O60264 | |
| TDLPTGWEEAYTFEG | 56 | Q9HAU0 | |
| EEYGRFDPSSWESVA | 571 | Q9NX78 | |
| EEWRSLDPSQTDFYG | 121 | Q96N77 | |
| DSETTYDWEYAGFTP | 641 | P82987 | |
| EDFEPSDSRVQYFWE | 761 | Q5T447 | |
| DNGGWSSFEEDDYES | 101 | Q13094 | |
| EFPSGLISVSYDDWD | 271 | Q12879 |